Is RPHM or DIVO a better dividend investment in 2026?

RPHM currently yields 10.99% with a 5% 5-year dividend growth rate. DIVO yields 6.62% with 5% growth. The better choice depends on your goal: RPHM offers higher current income.

What is the dividend yield difference between RPHM and DIVO?

RPHM has a forward dividend yield of 10.99% ($2.00/share annually). DIVO yields 6.62% ($2.91/share annually). The yield gap is 4.37 percentage points.

Home › Compare › RPHM vs DIVO

RPHM vs DIVO: Dividend Comparison 2026

RPHM yields 10.99% · DIVO yields 6.62%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RPHM wins by $10.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

RPHM

● Live price

10.99%

Share price

$18.20

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$41.3K

Annual income

$2,186.89

Full RPHM calculator →

DIVO

● Live price

6.62%

Share price

$44.00

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.0K

Annual income

$1,008.47

Full DIVO calculator →

Portfolio growth — RPHM vs DIVO

📍 RPHM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RPHM	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RPHM + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RPHM pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RPHM

Annual income on $10K today (after 15% tax)

$934.07/yr

After 10yr DRIP, annual income (after tax)

$1,858.86/yr

DIVO

Annual income on $10K today (after 15% tax)

$562.67/yr

After 10yr DRIP, annual income (after tax)

$857.20/yr

At 15% tax rate, RPHM beats the other by $1,001.66/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RPHM + DIVO for your $10,000?

RPHM: 50%DIVO: 50%

100% DIVO50/50100% RPHM

Portfolio after 10yr

$36.2K

Annual income

$1,597.68/yr

Blended yield

4.42%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on RPHM right now

RPHM

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-0.1

Piotroski

3/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RPHM buys

DIVO buys

No recent congressional trades found for RPHM or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRPHMDIVO

Forward yield	10.99% ✓	6.62%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$41.3K ✓	$31.0K
Annual income after 10y	$2,186.89 ✓	$1,008.47
Total dividends collected	$16.4K ✓	$8.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: RPHM vs DIVO ($10,000, DRIP)

Year	RPHM Portfolio	RPHM Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$11,799	$1,098.90	$11,362	$661.96	+$437.00 → RPHM
2	$13,837	$1,211.76	$12,860	$702.91	+$977.00 → RPHM
3	$16,133	$1,328.07	$14,504	$743.56	+$1.6K → RPHM
4	$18,710	$1,447.20	$16,303	$783.73	+$2.4K → RPHM
5	$21,588	$1,568.52	$18,268	$823.31	+$3.3K → RPHM
6	$24,791	$1,691.42	$20,408	$862.17	+$4.4K → RPHM
7	$28,341	$1,815.27	$22,737	$900.20	+$5.6K → RPHM
8	$32,264	$1,939.50	$25,266	$937.31	+$7.0K → RPHM
9	$36,587	$2,063.54	$28,008	$973.42	+$8.6K → RPHM
10	$41,334	$2,186.89	$30,977	$1,008.47	+$10.4K → RPHM

RPHM vs DIVO: Complete Analysis 2026

RPHM — Stock

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Full RPHM Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this RPHM vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RPHM vs SCHD RPHM vs JEPI RPHM vs O RPHM vs KO RPHM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.